Journal Buzz: Botulinum Toxin for Hidradenitis Suppurativa | The Expert Weighs In
Botulinum toxin is a safe and potentially effective treatment alternative in hidradenitis suppurativa (HS) patients who are resistant to standard therapies, according to the authors of a systematic review published in the Journal of Drugs in Dermatology.
How does this review add to the conversation about new treatments for HS? In which HS patients might dermatologists consider botulinum toxin as …
Botulinum toxin is a safe and potentially effective treatment alternative in hidradenitis suppurativa (HS) patients who are resistant to standard therapies, according to the authors of a systematic review published in the Journal of Drugs in Dermatology.
How does this review add to the conversation about new treatments for HS? In which HS patients might dermatologists consider botulinum toxin as … Continue reading "Journal Buzz: Botulinum Toxin for Hidradenitis Suppurativa | The Expert Weighs In"
Acne has profound effects on patients physically and psychologically.
Acne is the most common inflammatory dermatosis seen by Dermatologists with profound effects on patients both physically and psychologically.1 Although extensive research and evidence-based guidelines exist for treatment, most are based on short term randomized controlled trials, leaving a gap in understanding the longer-ter … 
JDD authors Hannah Polster MD, Karen Kagha MD, and Janiene Luke MD report a case of platelet rich plasma for the treatment of scarring alopecia due to discoid lupus erythematosus.
Platelet-rich plasma (PRP) is an autologous concentration of plasma from a patient's blood containing platelets up to 7 times higher than normal plasma.1 Originally indicated to improve connective tissue regeneratio … 
Our new series, “The Many Faces of”, showcases side-by-side images of some of the most commonly seen dermatology conditions in an array of skin tones and briefly highlight nuances in clinical presentation. All images featured in the series are part of The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas, a resource developed by co-editors Misty Eleryan, MD, MS, and Adam Friedman, … 
Dermatologists are prescribing oral glucocorticoids for psoriasis despite awareness of risks of life-threatening generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP). A recent survey of dermatologists published in the Journal of Drugs in Dermatology found 18% of respondents occasionally prescribe oral glucocorticoids to patients with psoriasis, typically 1-5% of the time. Those wh … 